Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

Engineered Vascularized Muscle Flap

Engineered Vascularized Muscle Flap

Published on: January 11, 2016

Tissue bioengineering for surgical bleb defects: an animal study.

Wei-Cherng Hsu¹, Robert Ritch, Theodore Krupin

¹Department of Ophthalmology, Buddhist Tzu Chi General Hospital Taipei Branch, Taipei, Taiwan, Republic of China. cyao@seed.net.tw

Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie

|February 13, 2008

Summary

OloGen implant effectively prevents bleb failure after trabeculectomy in rabbit eyes with wound defects. Histology confirmed OloGen acts as a scaffold, promoting healing and maintaining bleb size for better IOP control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Diagnostic Performance of Prespecified OCT Rules for Glaucomatous Optic Neuropathy in Nonpathologic Myopia.

JAMA ophthalmology·2026

Same author

Deep Learning in Glaucoma Detection and Progression Prediction: A Systematic Review and Meta-Analysis.

Biomedicines·2025

Same author

Comparing the morphology of optic nerve head and lamina cribrosa in full-term and preterm school-aged children.

Eye (London, England)·2024

Same author

Homocysteine and Glaucoma.

International journal of molecular sciences·2023

Same author

Vascular parameters and endothelin-1 measurements in glaucoma patients with low- and high-tension optic disc hemorrhages.

Scientific reports·2023

Same author

Abdominal aortic aneurysm and exfoliation syndrome in Utah.

Acta ophthalmologica·2022

Area of Science:

Ophthalmology
Biomaterials Science
Surgical Innovation

Background:

Trabeculectomy is a surgical procedure to treat glaucoma.
Poor bleb formation and early failure can compromise trabeculectomy outcomes.
OloGen (iGen) is a novel collagen-glycoaminoglycan matrix implant designed to improve surgical success.

Purpose of the Study:

To evaluate the efficacy of the OloGen implant in preventing inadequate bleb formation and early failure following trabeculectomy.
To assess the implant's role in managing surgical wound defects in glaucoma surgery.

Main Methods:

Trabeculectomy was performed on New Zealand albino rabbits, with OloGen implanted in the experimental group and a control group without the implant.
A standardized conjunctival defect was created in all eyes.

More Related Videos

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring

Published on: April 3, 2015

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs

Published on: July 5, 2024

Related Experiment Videos

Last Updated: Jul 7, 2026

Engineered Vascularized Muscle Flap

Engineered Vascularized Muscle Flap

Published on: January 11, 2016

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring

Published on: April 3, 2015

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs

Published on: July 5, 2024

Intraocular pressure (IOP), Seidel test, conjunctival defect size, and anterior chamber depth were monitored.

Histological analysis using H&E, Sirius, and Fast-green stains evaluated collagen deposition and cell migration.

Main Results:

No Seidel test-positive eyes or flat anterior chambers were observed in either group.
The OloGen implant group showed a significant reduction in mean IOP (35-42%) from day 14 to 28 compared to the control group (2-12%).
Histology revealed randomized collagen deposition and microcyst formation in the OloGen group, with complete matrix degradation by day 28, while the control group showed dense subconjunctival collagen.

Conclusions:

OloGen functions as a 3D scaffold, facilitating cell migration and proliferation.
The implant successfully prevents bleb failure in the presence of significant wound defects.
OloGen demonstrates potential for repairing postoperative bleb leaks and improving glaucoma surgery outcomes.